Join to View Full Profile
171 Ashley AveCharleston, SC 29425
Phone+1 843-792-1414
Dr. Bhatia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Topiwala National Medical CollegeClass of 2005
Medical University of South CarolinaResidency, Child Neurology- Medical University of South CarolinaFellowship, Epilepsy
Certifications & Licensure
CA State Medical License 2024 - 2027
CO State Medical License 2023 - 2027
NJ State Medical License 2023 - 2027
SC State Medical License 2015 - 2027
AK State Medical License 2023 - 2026
ID State Medical License 2023 - 2026
NY State Medical License 2005 - 2026
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology- American Board of Psychiatry and Neurology Epilepsy
- Join now to see all
Publications & Presentations
PubMed
- Characterizing CHD2-associated epilepsy: A multicenter study and pooled analysis of the literature.Anabel G Puri, Sean Woods, John M Schreiber, Cynthia G Keator, Jason Coryell
Seizure. 2025-09-04 - 1 citationsCurrent and Emerging Precision Therapies for Developmental and Epileptic Encephalopathies.Debopam Samanta, Sonal Bhatia, Senyene E Hunter, Chethan K Rao, Katherine Xiong
Pediatric Neurology. 2025-07-01 - Rebuilding the Tower of Babel: The Current Landscape and Emerging Opportunities in DEE-SWAS.Robert C Stowe, Sarah A Kelley, Sonal Bhatia, John R McLaren, Lekha M Rao
Epilepsy Currents. 2025-06-09
Press Mentions
- Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual MeetingNovember 3rd, 2023
- Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia BApril 30th, 2024
- FDA Approves CDx to Determine Gene Therapy Eligibility for Hemophilia B PatientsApril 30th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
